IL-15 protein complex pharmaceutical composition
US11273205B2 · kind B2 · utility
0Cited by
2References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 24, 2018 |
| Grant date | Mar 15, 2022 |
| Priority date | — |
| Expiry date | Jul 24, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/7155
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a pharmaceutical composition, which comprises an IL-15 protein complex and a citrate buffer solution. In addition, the pharmaceutical composition may also comprise a sugar and a non-ionic surfactant. The pharmaceutical composition in the present disclosure demonstrates a high degree of stability even after being stored at 2-8° C. for several months.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.